Key result
CCTA-derived FAI predicts new, high-risk, and obstructive coronary plaques beyond conventional clinical risk factors.
Why the study?
The study aimed to develop and validate a predictive model based on CCTA-derived fat attenuation index (FAI) for the formation of new, high-risk, and obstructive plaques.
Does CCTA-derived fat attenuation index (FAI) predict the formation of new, high-risk, and obstructive coronary plaques in patients with cardiovascular risk factors?
Cohort (n=220)
Does CCTA-derived fat attenuation index (FAI) predict the formation of new, high-risk, and obstructive coronary plaques in patients with cardiovascular risk factors?
Effect estimate: AUC 0.723 (95% CI 0.645-0.802)
p-value: p=< 0.001
CCTA-derived fat attenuation index (FAI) provides incremental predictive value over conventional clinical risk factors for identifying the formation of new, high-risk, and obstructive coronary plaques.
Fat attenuation index may aid plaque risk stratification beyond clinical factors; hypothesis-generating and requires prospective validation before practice change.
AIM: To develop and validate a predictive model based on CCTA-derived fat attenuation index (FAI) for the formation of new, high-risk, and obstructive plaques. MATERIALS AND METHODS: This research retrospectively included 160 patients with cardiovascular risk factors for model development and 60 patients for external verification. All patients underwent at least two CCTA examinations within a 5-year period, and initial results were normal. Newly formed plaques, along with their vulnerability and luminal stenosis was assessed. The FAI was quantitatively evaluated on the three major coronary arteries with the initial CCTA. RESULTS: Among 160 participants, newly formed plaques were identified in 60 patients. FAI had a certain value in predicting new (area under the curve (AUC) 0.723 [95% CI: 0.645, 0.802], with a cut-off value of -80.5 HU, sensitivity of 73.3% and specificity of 64.0%), high-risk (AUC 0.822 [95% CI: 0.715, 0.929], with a cut-off value of -78.5 HU, sensitivity of 90.9% and specificity of 65.3%), and obstructive (AUC 0.823 [95% CI: 0.720, 0.926], with a cut-off value of -77.5 HU, sensitivity of 90.0% and specificity of 74.0%) plaques and exhibited an incremental value compared with conventional clinical risk factors (0.817 vs 0.749; 0.862 vs. 0.700; 0.876 vs 0.740, all P < 0.001). CONCLUSION: FAI and cardiovascular risk factors aided in predicting the probability of coronary plaque formation (FAI: -80.5 HU), especially high-risk (FAI: -78.5 HU) and obstructive (FAI: -77.5 HU) plaques.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) conducted a cohort in Cardiovascular risk factors (n=220). CCTA-derived fat attenuation index (FAI) vs. Conventional clinical risk factors was evaluated on Formation of new plaques (AUC 0.723, 95% CI 0.645-0.802, p=< 0.001). CCTA-derived fat attenuation index predicted the formation of new (AUC 0.723), high-risk (AUC 0.822), and obstructive (AUC 0.823) coronary plaques, adding incremental value to clinical risk factors.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: